InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Explore the complete record of transactions filed by Lizak Carol R., 首席财务官. Officer active across 1 company, notably Jaguar Health, Inc.. Cumulatively, 9 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €17k. Activity tracked since 13 September 2021. The latest transaction was filed on 11 December 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Lizak Carol R. is Chief Financial Officer at Jaguar Health, Inc. The declarant has 9 filings in total, and the sampled recent filings cover the period from 2022-03-30 to 2025-12-15, with EUR 16932 of buys and EUR 0 of sells, the most common transaction nature being option exercise.